Abstract
The invention relates to microparticles that may be used for antigen delivery and vaccine immunization strategies. The invention in particular relates to microparticles that are useful in the prophylaxis and treatment of human immunodeficiency virus (HIV) infections.
Lingua originale | Inglese |
---|---|
Numero di brevetto | PCT/EP2004/012421 |
Stato di pubblicazione | Pubblicato - 1 gen 2003 |